FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883201900> ?p ?o ?g. }

• W2883201900 endingPage "8" @default.
• W2883201900 startingPage "1" @default.
• W2883201900 abstract "Neonatal systemic inflammatory response and multiple organ dysfunction syndrome are the main postnatal insults influencing mortality and morbidity. Critically ill newborns with high predicted mortality are supported by extracorporeal membrane oxygenation (ECMO). Biomarkers of inflammatory response and endothelial injury can be used for early diagnosis and treatment of critical neonatal situations. The aim of our study was to explore plasma proteins and endothelial microvesicles as markers of inflammation and endothelial activation in newborns on ECMO and to compare them with healthy neonates. Thirteen newborns on ECMO and 13 healthy newborns were included in the study. Plasma soluble biomarkers were measured using multiplex immunoassay based on Luminex® xMAP multianalyte profiling platform. The total microvesicle count and plasma level of surface antigen-specific microvesicles were determined by flow cytometry. The plasma concentration of cell-derived microvesicles was measured using annexin-V labeling, and the endothelial origin of microvesicles was determined using lineage-specific antigen labeling of endothelial cell/microvesicle markers (endoglin/CD105, PECAM1/CD31, VEGFR2/CD309, and MadCAM1). Inflammatory markers (procalcitonin, IL-1 β , IL-6, and IL-22) were increased in the ECMO group (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M1><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.01</mml:mn></mml:math>). The assessment of endothelial markers showed higher concentrations of endocan and angiopoietin-2 (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M2><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.01</mml:mn></mml:math>) in the ECMO group while VEGF in the ECMO group was significantly lower (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M3><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.01</mml:mn></mml:math>). In the ECMO group, the concentration of annexin-V-positive microvesicles (total microvesicles) and endothelial microvesicles expressing mucosal vascular addressin cell adhesion molecule 1 (MadCAM1) was increased (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M4><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn>0.05</mml:mn></mml:math>). In summary, we found increased concentrations of soluble inflammatory and endothelial markers in the plasma of critically ill newborns with multiple organ dysfunction. Increased plasma concentrations of microvesicles may reflect the activation or damage of blood cells and vasculature including endothelial cells. The measurement of cell membrane-derived microvesicles may be added to the panel of established inflammatory markers in order to increase the sensitivity and specificity of the diagnostic process in critically ill newborns." @default.
• W2883201900 created "2018-08-03" @default.
• W2883201900 creator A5004964166 @default.
• W2883201900 creator A5007587640 @default.
• W2883201900 creator A5023584418 @default.
• W2883201900 creator A5033185918 @default.
• W2883201900 creator A5050471755 @default.
• W2883201900 creator A5068748520 @default.
• W2883201900 creator A5069341361 @default.
• W2883201900 creator A5091646107 @default.
• W2883201900 date "2018-07-19" @default.
• W2883201900 modified "2023-10-09" @default.
• W2883201900 title "Endothelial Microvesicles and Soluble Markers of Endothelial Injury in Critically Ill Newborns" @default.
• W2883201900 cites W1737926689 @default.
• W2883201900 cites W193616686 @default.
• W2883201900 cites W1970603429 @default.
• W2883201900 cites W1971947376 @default.
• W2883201900 cites W1973643187 @default.
• W2883201900 cites W1982783885 @default.
• W2883201900 cites W1983763042 @default.
• W2883201900 cites W1986809030 @default.
• W2883201900 cites W1987903108 @default.
• W2883201900 cites W1989045203 @default.
• W2883201900 cites W1992542743 @default.
• W2883201900 cites W1997405714 @default.
• W2883201900 cites W2002382373 @default.
• W2883201900 cites W2010326778 @default.
• W2883201900 cites W2016665689 @default.
• W2883201900 cites W2022554516 @default.
• W2883201900 cites W2032497440 @default.
• W2883201900 cites W2053972219 @default.
• W2883201900 cites W2067437365 @default.
• W2883201900 cites W2068796527 @default.
• W2883201900 cites W2068959356 @default.
• W2883201900 cites W2070039198 @default.
• W2883201900 cites W2077049963 @default.
• W2883201900 cites W2093424639 @default.
• W2883201900 cites W2106021002 @default.
• W2883201900 cites W2128670961 @default.
• W2883201900 cites W2132377148 @default.
• W2883201900 cites W2133760133 @default.
• W2883201900 cites W2150635114 @default.
• W2883201900 cites W2193970424 @default.
• W2883201900 cites W2464282026 @default.
• W2883201900 cites W2610130212 @default.
• W2883201900 cites W2782824326 @default.
• W2883201900 doi "https://doi.org/10.1155/2018/1975056" @default.
• W2883201900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6079510" @default.
• W2883201900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30116143" @default.
• W2883201900 hasPublicationYear "2018" @default.
• W2883201900 type Work @default.
• W2883201900 sameAs 2883201900 @default.
• W2883201900 citedByCount "14" @default.
• W2883201900 countsByYear W28832019002019 @default.
• W2883201900 countsByYear W28832019002020 @default.
• W2883201900 countsByYear W28832019002021 @default.
• W2883201900 countsByYear W28832019002022 @default.
• W2883201900 countsByYear W28832019002023 @default.
• W2883201900 crossrefType "journal-article" @default.
• W2883201900 hasAuthorship W2883201900A5004964166 @default.
• W2883201900 hasAuthorship W2883201900A5007587640 @default.
• W2883201900 hasAuthorship W2883201900A5023584418 @default.
• W2883201900 hasAuthorship W2883201900A5033185918 @default.
• W2883201900 hasAuthorship W2883201900A5050471755 @default.
• W2883201900 hasAuthorship W2883201900A5068748520 @default.
• W2883201900 hasAuthorship W2883201900A5069341361 @default.
• W2883201900 hasAuthorship W2883201900A5091646107 @default.
• W2883201900 hasBestOaLocation W28832019001 @default.
• W2883201900 hasConcept C104317684 @default.
• W2883201900 hasConcept C126322002 @default.
• W2883201900 hasConcept C145059251 @default.
• W2883201900 hasConcept C16685009 @default.
• W2883201900 hasConcept C203014093 @default.
• W2883201900 hasConcept C20518536 @default.
• W2883201900 hasConcept C2780972559 @default.
• W2883201900 hasConcept C2909763251 @default.
• W2883201900 hasConcept C30345302 @default.
• W2883201900 hasConcept C553184892 @default.
• W2883201900 hasConcept C55493867 @default.
• W2883201900 hasConcept C71924100 @default.
• W2883201900 hasConcept C86803240 @default.
• W2883201900 hasConcept C88634738 @default.
• W2883201900 hasConceptScore W2883201900C104317684 @default.
• W2883201900 hasConceptScore W2883201900C126322002 @default.
• W2883201900 hasConceptScore W2883201900C145059251 @default.
• W2883201900 hasConceptScore W2883201900C16685009 @default.
• W2883201900 hasConceptScore W2883201900C203014093 @default.
• W2883201900 hasConceptScore W2883201900C20518536 @default.
• W2883201900 hasConceptScore W2883201900C2780972559 @default.
• W2883201900 hasConceptScore W2883201900C2909763251 @default.
• W2883201900 hasConceptScore W2883201900C30345302 @default.
• W2883201900 hasConceptScore W2883201900C553184892 @default.
• W2883201900 hasConceptScore W2883201900C55493867 @default.
• W2883201900 hasConceptScore W2883201900C71924100 @default.
• W2883201900 hasConceptScore W2883201900C86803240 @default.
• W2883201900 hasConceptScore W2883201900C88634738 @default.
• W2883201900 hasFunder F4320321798 @default.
• W2883201900 hasLocation W28832019001 @default.

• next